Norway
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 476.64 M
|
Dec. 31, 2023 | USD 17.56 | 0.15% |
|
Norway |
|
2 |
USD 47.40 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
3 |
USD 30.37 M
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
|
4 |
USD 27.43 M
|
Dec. 31, 2023 | USD 0.19 | -0.80% |
|
Norway |
|
5 |
USD 21.83 M
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
6 |
USD 14.40 M
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
7 |
USD 6.52 M
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
8 |
USD 4.11 M
|
Dec. 31, 2023 | USD 0.27 | 1.85% |
|
Norway |
The Biotechnology company in Norway with the highest Shareholders' Equity is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 476.64 M.
The Biotechnology company in Norway with the lowest Shareholders' Equity is Hofseth BioCare ASA (Oslo Stock Exchange: HBC.OL) at USD 4.11 M.
The top 10 Biotechnology companies in Norway by Shareholders' Equity are Borregaard ASA, Photocure ASA, ArcticZymes Technologies ASA, Ultimovacs ASA, Navamedic ASA, Gentian Diagnostics ASA, Lifecare AS and Hofseth BioCare ASA.
The bottom 10 Biotechnology companies in Norway by Shareholders' Equity are Hofseth BioCare ASA, Lifecare AS, Gentian Diagnostics ASA, Navamedic ASA, Ultimovacs ASA, ArcticZymes Technologies ASA, Photocure ASA and Borregaard ASA.